to minors if allowed to go into effect. Sex reassignment surgery is not performed on minors in Arkansas. The effect of puberty blockers is shown to be fully reversible. Research is still ongoing as to any potential long term effects or impacts on the developing brain. The American Academy of Pediatricians recommends avoiding stigma and providing gender-affirming treatment for transgender youth as the best way to prevent anxiety, stress, and suicide. In support of the ban, Arkansas state representative Mary Bentley quoted , and Rep. Jim Wooten said transgender children were equivalent to a child who "comes to you and says, 'I wanna be a cow.'" Other critics called the treatment "genital mutilation" and "experimentation". Texas In February 2022, Texas Attorney General Ken Paxton issued a legal opinion that considered child medical gender transition to be child abuse under state law. This was followed by Texas Governor Greg Abbott calling on state officials to investigate anyone who provided gender affirming treatment to a child. Abbott also called on both "licensed professionals" and "members of the general public" to report any trans minors or parents of trans minors to the state, with "criminal penalties" for those who knowingly fail to report. After this, five District Attorneys said they would not be following the order. The ACLU and Lambda Legal sued over the order and many medical groups have condemned it. In March 2022, the Texas Third Court of Appeals reinstated a temporary injunction barring enforcement of Abbott's directive. Randy Mulanax, investigative supervisor with the Texas DFPS, testified in court that cases regarding trans children were being subject to different rules than other cases, with investigation of any child reported, regardless of evidence, being mandatory, and investigators being prohibited from discussing the case over email or text. In July 2022, Yale University released a point by point rebuttal of the justifications given by Texas and Alabama for their bans on youth gender affirming care, stating that puberty blockers and hormone therapies are in fact safe and effective for treating gender dysphoria, that "these are not close calls or areas of reasonable disagreement", and that both states "ignore established medical authorities and repeat discredited, outdated, and poor-quality information" and repeatedly cite "a fringe group whose listed advisors have limited (or no) scientific and medical credentials and include well known anti-trans activists". Idaho In March 2022, the Idaho House approved H.675—a piece of legislation